Diadema Partners »

Erasca shares owned by Diadema Partners

Quarter-by-quarter ownership of Erasca (ERAS) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Erasca

Tip: Access up to 7 years of quarterly data

All positions including Erasca held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Erasca by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.8k 100 18.32

More positions owned by Diadema Partners

Abivax Sa Sponsored Ads Call Option (ABVX)
Viking Therapeutics (VKTX)
Bristol Myers Squibb Put Option (BMY)
Amgen Call Option (AMGN)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Uniqure Nv SHS Put Option (QURE)
Novartis Sponsored Adr Call Option (NVS)
Kodiak Sciences Call Option (KOD)
Capricor Therapeutics Com New Put Option (CAPR)
Cogent Biosciences (COGT)
Bridgebio Pharma Note 1.750% 3/0 (Principal)
Corcept Therapeutics Incorporated Call Option (CORT)
BioMarin Pharmaceutical (BMRN)
Kymera Therapeutics Call Option (KYMR)

View all positions for Diadema Partners

Top funds holding Erasca

Frazier Life Sciences Management
BlackRock
Rtw Investments
VR Adviser
Logos Global Management
Vanguard Capital Management
Siren
Paradigm Biocapital Advisors
State Street Corporation
Arch Venture Corp
Geode Capital Management
Cormorant Asset Management
Caption Management
Affinity Asset Advisors
Vivo Capital

View all funds holding Erasca